Intensity Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.

About INTS

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. 

CEO
Lewis H. Bender
CEOLewis H. Bender
Employees
16
Employees16
Headquarters
Shelton, Connecticut
HeadquartersShelton, Connecticut
Founded
2012
Founded2012
Employees
16
Employees16

INTS Key Statistics

Market cap
12.93M
Market cap12.93M
Price-Earnings ratio
-0.82
Price-Earnings ratio-0.82
Dividend yield
Dividend yield
Average volume
29.31K
Average volume29.31K
High today
$4.19
High today$4.19
Low today
$3.90
Low today$3.90
Open price
$3.91
Open price$3.91
Volume
38.95K
Volume38.95K
52 Week high
$43.50
52 Week high$43.50
52 Week low
$3.51
52 Week low$3.51

Stock Snapshot

Intensity Therapeutics(INTS) stock is priced at $3.95, giving the company a market capitalization of 12.93M. It carries a P/E multiple of -0.82.

During the trading session on 2026-08-15, Intensity Therapeutics(INTS) shares reached a daily high of $4.19 and a low of $3.90. At a current price of $3.95, the stock is +1.3% higher than the low and still -5.7% under the high.

Trading volume for Intensity Therapeutics(INTS) stock has reached 38.95K, versus its average volume of 29.31K.

Over the past 52 weeks, Intensity Therapeutics(INTS) stock has traded between a high of $43.50 and a low of $3.51.

Over the past 52 weeks, Intensity Therapeutics(INTS) stock has traded between a high of $43.50 and a low of $3.51.

INTS News

Investing.com 4d
Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket - Investing.com

...

Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket - Investing.com

People also own

Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.